The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate

Clinical trial NCT06641128 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06641128
Sponsor: Tanta University
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Methotrexate Induced Nephrotoxicity Methotrexate Adverse Reaction

Start date: 2024-10-15
Primary completion: 2025-03-10
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.